Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Leah Sansbury"'
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 33, Iss 1, Pp 1-9 (2023)
Abstract This study investigated burden of ‘not well-controlled’ asthma, overall and by Global Initiative for Asthma (GINA) Step, among treated asthma patients in Practice Fusion’s research database. Asthma control (Asthma Control Test [ACT]) w
Externí odkaz:
https://doaj.org/article/c896c58b613c4896b7f36a763f5a2453
Autor:
Andreas, Nikolaou, Cosmina, Hogea, Yevgeniy, Samyshkin, Eric M, Maiese, Leah, Sansbury, Mustafa, Oguz, Javier, Cid-Ruzafa, Ritika, Kapoor, Feng, Wang
Publikováno v:
Value in Health. 25:1977-1985
Estimates on the distribution of patients with multiple myeloma (MM) by line of therapy (LOT) are scarce and get outdated quickly as new treatments become available. The objective of this study was to estimate the number of patients with MM by LOT an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f9cfa14917be5e9f29ed02fb7576ec
https://doi.org/10.1016/j.jval.2022.05.011
https://doi.org/10.1016/j.jval.2022.05.011
Autor:
Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather, Chris Compton
Publikováno v:
ERJ Open Research, Vol 5, Iss 4 (2019)
Effectiveness studies complement conventional randomised controlled trials by providing a holistic view of treatments in the setting of usual clinical practice. We present the protocol for the ongoing INTREPID (INvestigation of TRelegy Effectiveness:
Externí odkaz:
https://doaj.org/article/2991a2b300fb4a648e86aa3265cce6df
Autor:
Antoine Bessou, Xavier Colin, Julie De Nascimento, Will Sopwith, Shannon Ferrante, Boris Gorsh, Benjamin Gutierrez, Leah Sansbury, Jenny Willson, Sandhya Sapra, Prani Paka, Feng Wang
Publikováno v:
The European Journal of Health Economics. 24:321-333
Background Real-world data on health care resource utilisation (HCRU) and costs for French patients with multiple myeloma (MM) are limited due to the quickly evolving MM treatment landscape. This retrospective, national-level study quantified the MM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc35048a9e07acf3151a90ad0b092b7
https://doi.org/10.1007/s10198-022-01463-9
https://doi.org/10.1007/s10198-022-01463-9
Publikováno v:
Future Oncology. 17:921-930
Aim: To report the results of a patient epidemiology model for multiple myeloma (MM) treatment by line of therapy (LOT) in the USA. Materials & methods: Surveillance, Epidemiology and End Results registry data and physician surveys were combined to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467e75d9a561c64fe125b8d80cdef0b7
https://doi.org/10.2217/fon-2020-0970
https://doi.org/10.2217/fon-2020-0970
Autor:
Eric M. Maiese, Robert S. Smith, Shannon Ferrante, Prateesh Varughese, Natalie Dorrow, Trudy Buckingham, Cosmina Hogea, Leah Sansbury, Mei Xue
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S419-S420
Context Most patients with MM become refractory to proteasome inhibitors (PIs), immunomodulatory drugs, and anti-CD38 monoclonal antibodies; limited evidence indicates these patients have poor outcomes. A US retrospective study showed that 275 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f15383568a2da65e1b1ed5bbac9a111
https://doi.org/10.1016/s2152-2650(21)01941-8
https://doi.org/10.1016/s2152-2650(21)01941-8
Autor:
Tatia Woodward, Linda Kalilani, Jessica Perhanidis, Antonio González-Martín, Leah Sansbury, Dana M. Chase, Divya Gupta
Publikováno v:
Ovarian cancer.
Introduction/Background Although most patients with ovarian cancer (OC) respond to first line (1L) treatment, 70% of women experience disease progression (PD) within 3 years. Identifying prognostic factors that impact survival is crucial to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3607e7482acd9ec76aae2e58365751a5
https://doi.org/10.1136/ijgc-2020-esgo.128
https://doi.org/10.1136/ijgc-2020-esgo.128
Autor:
Antonio González-Martín, MD, PhD, Tatia Woodward, Leah Sansbury, Linda Kalilani, Divya Gupta, Jessica Perhanidis, Dana Chase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96f17df816cde864b80f823dc10da6ba
https://doi.org/10.26226/morressier.5fa3ee5d55b1fd4cc4dd93eb
https://doi.org/10.26226/morressier.5fa3ee5d55b1fd4cc4dd93eb
Publikováno v:
Airway pharmacology and treatment.
Background: Previous real-world studies suggest multiple-inhaler triple therapy (MITT; ICS/LAMA/LABA) is overused and incorrectly positioned within the COPD treatment pathway. Addressing the timing of MITT initiation in COPD care to optimise patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49d0b49aecb59e8597dc91ef7f0f62d2
https://doi.org/10.1183/13993003.congress-2020.2426
https://doi.org/10.1183/13993003.congress-2020.2426
Publikováno v:
Airway pharmacology and treatment.
Introduction: Current Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend triple therapy for chronic obstructive pulmonary disease (COPD) patients who continue to exacerbate or who remain breathless despite maintenance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36b192ec9dfda6d4f364d41e68a1de4a
https://doi.org/10.1183/13993003.congress-2020.2417
https://doi.org/10.1183/13993003.congress-2020.2417